Susquehanna International Group, LLP Cara Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 16, 2023	SELL	$4.89 - $12.27 $59,657 - $149,694	-12,200 Reduced 51.69%	11,400 $55,000
Q4 2022 Feb 14, 2023	SELL	$8.88 - $12.77 $377,400 - $542,725	-42,500 Reduced 64.3%	23,600 $253,000
Q3 2022 Nov 14, 2022	BUY	$8.24 - $12.56 $218,360 - $332,840	26,500 Added 66.92%	66,100 $619,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.